z-logo
open-access-imgOpen Access
Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk
Author(s) -
Zoe Moodie,
One Dintwe,
Sheetal Sawant,
Douglas I. Grove,
Yunda Huang,
Holly Janes,
Jack Heptinstall,
Faatima Laher Omar,
Kristen W. Cohen,
Stephen C. De Rosa,
Lu Zhang,
Nicole L. Yates,
Marcella SarzottiKelsoe,
Kelly E. Seaton,
Fatima Laher,
Linda Gail Bekker,
Mookho Malahleha,
Craig Innes,
Sheetal Kassim,
Nivashnee Naicker,
Vaneshree Govender,
Modulakgotla Sebe,
Nishanta Singh,
Philip Kotze,
Erica Lazarus,
Maphoshane Nchabeleng,
Amy Ward,
William Brumskine,
Thozama Dubula,
April Randhawa,
Nicole Grunenberg,
John Hural,
Jia Jin Kee,
David Benkeser,
Yutong Jin,
Lindsay N. Carpp,
Mary Allen,
Patricia D’Souza,
James Tartaglia,
Carlos A. DiazGranados,
Marguerite Koutsoukos,
Peter B. Gilbert,
James G. Kublin,
Lawrence Corey,
Erica AndersenNissen,
Glenda Gray,
Georgia D. Tomaras,
M Juliana McElrath
Publication year - 2022
Publication title -
zenodo (cern european organization for nuclear research)
Language(s) - English
DOI - 10.5281/zenodo.7071884
Subject(s) - hiv vaccine , human immunodeficiency virus (hiv) , vaccine trial , medicine , aids vaccines , antibody , virology , clinical trial , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here